Search Results

You are looking at 91 - 100 of 124 items for :

  • "papillary" x
  • Refine by Access: All x
Clear All
Full access

Jeffrey F. Moley

Hauptmann S Dralle H . Prediction of lateral lymph node metastases in medullary thyroid cancer . Br J Surg 2008 ; 95 : 586 – 591 . 24. Solorzano CC Evans DB . Same-day ultrasound guidance in reoperations for locally recurrent papillary

Full access

Robert J. Morgan Jr, Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O’Malley, Richard T. Penson, Matthew A. Powell, Steven W. Remmenga, Paul Sabbatini, Joseph T. Santoso, Julian C. Schink, Nelson Teng, Theresa L. Werner, Mary A. Dwyer, and Miranda Hughes

, although MMMT has not been included in IP chemotherapy trials. 21 , 38 However, MMMT/carcinosarcoma is basically papillary serous carcinoma (ie, a poorly differentiated carcinoma); therefore, IP may be used for MMMT. NCCN Guidelines Insights

Full access

John P. Sherbeck, Lili Zhao, and Richard W. Lieberman

. Int J Gynecol Cancer 2015 ; 25 : 1437 – 1444 . 5. Alagkiozidis I Weedon J Grossman A . Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: a

Full access

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Featured Updates to the NCCN Guidelines

Robert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi Haas, Michael R. Harrison, Elizabeth R. Plimack, Jeffrey Sosman, Neeraj Agarwal, Sam Bhayani, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Thomas H. Gallagher, Steven L. Hancock, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, Bryan Lewis, Brandon Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley Somer, Geoffrey Wile, Mary A. Dwyer, CGC, Lydia J. Hammond, and Griselda Zuccarino-Catania

, multicenter study . J Clin Oncol 2009 ; 27 : 5794 – 5799 . 19826129 10.1200/JCO.2008.21.4809 17. Ficarra V , Schips L , Guillè F , . Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized

Full access

Yue Chen, Zi-Qi Zheng, Fo-Ping Chen, Jian-Ye Yan, Xiao-Dan Huang, Feng Li, Ying Sun, and Guan-Qun Zhou

28628563 11. Suh YJ , Kwon H , Kim SJ , . Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery: a retrospective analysis of 3381 patients . Ann Surg Oncol 2015 ; 22 : 3543 – 3549 . 25743326 10

Full access

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea

variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer . Ann Surg Oncol 2006 ; 13 : 1063 – 1071 . 54. Wu AW Wang MB Nguyen CT . Surgical practice patterns in the treatment of papillary thyroid

Full access

Robert J. Morgan Jr, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-may Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Sanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns, and Miranda Hughes

endometrioid carcinomas, clear cell carcinomas, and papillary serous carcinomas. 9 – 11 In women at high risk (with either BRCA1 or BRCA2 mutations), prophylactic bilateral salpingooophorectomy (BSO) is associated with a reduced risk for breast, ovarian

Full access

Matthew F. Kalady

appearance is the recognition of type II open pits, which are thought to represent dilated crypt bases that are wider and rounder than the papillary or stellate (type II) pits found in the HPs and TSAs. This finding was associated with BRAF mutations and

Full access

Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston

common, more frequently bilateral (30%–40%), confined to the ovaries, and likely to exhibit benign behavior even at higher stages. 39 , 40 Updated genetic assessments suggest that seromucinous BOTs do not have a serous component despite some papillary

Full access

Rishi Jain, Michelle J. Savage, Andrea D. Forman, Reetu Mukherji, and Michael J. Hall

mutations and the risk of papillary thyroid cancer . Int J Cancer 2015 ; 137 : 548 – 552 . 52. Friedrichsen DM Malone KE Doody DR . Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women